SCHEMBL3783306

SCHEMBL3783306

CCCCc1cc(Cl)ccc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SKP2 Q13309 1/20 0.46
CYP3A4 P08684 4/20 0.45
TSHR P16473 3/20 0.45
ALOX15 P16050 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
TLR8 Q9NR97 2/20 0.40
CTRC Q99895 1/20 0.40
TYR P14679 1/20 0.39
TP53 P04637 1/20 0.39
SIRT1 Q96EB6 1/20 0.38
HPGD P15428 2/20 0.36
ALOX12 P18054 2/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.36
NR4A2 P43354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790391 0.88 CYP3A4 (0.48) SKP2CYP3A4TSHRALOX15SMN1; SMN2
SCHEMBL3789810 0.85 CYP3A4 (0.45) SKP2CYP3A4TSHRALOX15SMN1; SMN2
SCHEMBL12533057 0.81 CYP3A4 (0.45) CYP3A4TSHRALOX15SMN1; SMN2ALDH1A1
SCHEMBL18856191 0.80 TAAR1 (0.43) CYP3A4TSHRALOX15SMN1; SMN2ALDH1A1
SCHEMBL30227228 0.80 SKP2 (0.48) SKP2CYP3A4TSHRALOX15ALDH1A1
SCHEMBL39005 0.80 SKP2 (0.48) SKP2CYP3A4TSHRALOX15ALDH1A1
SCHEMBL5377476 0.80 SKP2 (0.48) SKP2CYP3A4TSHRALOX15SMN1; SMN2
SCHEMBL8641170 0.80 MEN1 (0.44) CYP3A4TSHRALOX15SMN1; SMN2ALDH1A1
SCHEMBL30645684 0.80 MEN1 (0.44) CYP3A4TSHRALOX15SMN1; SMN2ALDH1A1
SCHEMBL3786384 0.79 CYP3A4 (0.52) CYP3A4TSHRALOX15SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 SKP2 2544/4885CYP3A4 177/4885TSHR 1688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.